AAAAAA

   
Results: 1-25 | 26-50 | 51-75 |
Results: 51-75/75
HUMAN CYTOMEGALOVIRUS DNA IS PRESENT IN CD45(-INFECTED PATIENTS() CELLS IN SEMEN FROM HUMAN IMMUNODEFICIENCY VIRUS)
Authors: RASMUSSEN L MORRIS S HAMED K MERIGAN TC
Citation: L. Rasmussen et al., HUMAN CYTOMEGALOVIRUS DNA IS PRESENT IN CD45(-INFECTED PATIENTS() CELLS IN SEMEN FROM HUMAN IMMUNODEFICIENCY VIRUS), The Journal of infectious diseases, 171(2), 1995, pp. 432-436
QUANTITATION OF HUMAN CYTOMEGALOVIRUS DNA FROM PERIPHERAL-BLOOD CELLSOF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS COULD PREDICT CYTOMEGALOVIRUS RETINITIS
Authors: RASMUSSEN L MORRIS S ZIPETO D FESSEL J WOLITZ R DOWLING A MERIGAN TC
Citation: L. Rasmussen et al., QUANTITATION OF HUMAN CYTOMEGALOVIRUS DNA FROM PERIPHERAL-BLOOD CELLSOF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS COULD PREDICT CYTOMEGALOVIRUS RETINITIS, The Journal of infectious diseases, 171(1), 1995, pp. 177-182
CHARACTERIZATION OF HLA-A-ASTERISK-0201-RESTRICTED CYTOTOXIC T-CELL EPITOPES IN CONSERVED REGIONS OF THE HIV TYPE-1 GP160 PROTEIN
Authors: DUPUIS M KUNDU SK MERIGAN TC
Citation: M. Dupuis et al., CHARACTERIZATION OF HLA-A-ASTERISK-0201-RESTRICTED CYTOTOXIC T-CELL EPITOPES IN CONSERVED REGIONS OF THE HIV TYPE-1 GP160 PROTEIN, The Journal of immunology, 155(4), 1995, pp. 2232-2239
RANDOMIZED STUDY OF DIDANOSINE MONOTHERAPY AND COMBINATION THERAPY WITH ZIDOVUDINE IN HEMOPHILIC AND NONHEMOPHILIC SUBJECTS WITH ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION
Authors: RAGNI MV LOFARO ML DEGRUTTOLA V VANDERHORST C EYSTER ME KESSLER CM GJERSET GF HO M PARENTI DM DAFNI U RASHEED S KORVICK JA MERIGAN TC FISCUS S GUPTA P KATZMAN M SHAFER R MEYER WS COOMBS RW LANDRY BS KASDAN P NERHOOD L STOWELL R KAZIAL K BROWNSTEIN A KRAMER AS WASSERMAN S BLOODGOOD K MCMAHON D SUPERDOCK B ISRAELSKI DM CAIN P CARFAGNA E QUINLAN C HAWLEY P LELACHEUR SF MUENCH L COLLIER AC CHENG L LI XY MORSE G
Citation: Mv. Ragni et al., RANDOMIZED STUDY OF DIDANOSINE MONOTHERAPY AND COMBINATION THERAPY WITH ZIDOVUDINE IN HEMOPHILIC AND NONHEMOPHILIC SUBJECTS WITH ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION, Blood, 85(9), 1995, pp. 2337-2346
ZIDOVUDINE COMPARED WITH DIDANOSINE IN PATIENTS WITH ADVANCED HIV TYPE-1 INFECTION AND LITTLE OR NO PREVIOUS EXPERIENCE WITH ZIDOVUDINE
Authors: DOLIN R AMATO DA FISCHL MA PETTINELLI C BELTANGADY M LIOU SH BROWN MJ CROSS AP HIRSCH MS HARDY WD MILDVAN D BLAIR DC POWDERLY WG PARA MF FIFE KH STEIGBIGEL RT SMALDONE L CRUMPACKER CS COOLEY T MITSUYASO RT JOHN R SANDERS C REITMAN D HEWITT R REICHMAN RC GELB LD MCGUIRE ML JONES M NEIDIG JL ZWICKL B HARTMAN PB ROARKE ME BURK RA FUHRER J SOMOGYI KA SEPKOWITZ K TELZAK EE MCAULIFFE VJ VALENTINE FT VASQUEZ M MERIGAN TC KATZENSTEIN D FESSELL J HAVLIR DV RICHMAN DD SPECTOR SA KAHN JO JOHNSON L COLEMAN R HO M MCMAHON D PAZIN G ANTONISKIS D MCNAMARA B DIAMOND D COLLIER AC PARADISE MA WALD A DEPAOLISJONES A HENRY K WASKIN HA HYSLOP NE MUSHATT DM ZACHARY JA SOEIRO R HARRIS C ZINGMAN B GIORDANO MF SLEDZ S MURRAY HW CAREY JT DAVIS TL BAGBY B KESSLER HA MURPHY RL HIRSCHTICK RE CHEESEMAN SH LAI KK FAIRCHILD PG EHMANN WC ZURLO JJ MILLARD R TROIANI L HEGGEN AA VANDERHORST CM MCKINLEY GF GRIECO MH KOLATCH BR GOLDSMITH JC GOMPERTS ED WOODS LM GRUE L MAYJO K BECKER RL JAYAWEERA DT ROLFE L COLE J JERMANO J
Citation: R. Dolin et al., ZIDOVUDINE COMPARED WITH DIDANOSINE IN PATIENTS WITH ADVANCED HIV TYPE-1 INFECTION AND LITTLE OR NO PREVIOUS EXPERIENCE WITH ZIDOVUDINE, Archives of internal medicine, 155(9), 1995, pp. 961-974
COMBINATION AND MONOTHERAPY WITH ZIDOVUDINE AND ZALCITABINE IN PATIENTS WITH ADVANCED HIV DISEASE
Authors: FISCHL MA STANLEY K COLLIER AC ARDUINO JM STEIN DS FEINBERG JE ALLAN JD GOLDSMITH JC POWDERLY WG RAINES CP MAYJO KJ KERULY JC CRAVEN D HIRSHORN L HIRSCH MS JAYAWEERA DT YOUNG SW PATRONEREESE J BRETTLER D SPERBER K GERITS P SEREMETIS S GILL JC GELB LD MCGUIRE ML STIFFLER T LEDERMAN MM CAREY JT WALLACE M MACARTHUR RD BERGE P MILDVAN D COREY L COOMBS RW CUMMINGS DK SCHOOLEY RT RAY MG WAITE V KURITZKES DR FUHRER J TENZLER RJ DONLON W VANDERHORST CM TROIANI L HORTON J LANE TW MURPHY RR PHAIR JP KESSLER HA BENSON CA ROSENWALD V YONREN S VALENTINE F HASLETT P MITSUYASU RT GUERRO M GOETZ MB MATHISEN GE FRAME PT BRINKDOPKE J POWELL T HOELLE M MERIGAN TC SHAFER R CAIN P FESSELL J HENRY K RHAME F CHRISTENSON J STRYKE D ZINGMAN B KAHL P SOEIRO R CHOI YS REICHMAN RL REID J BLAIR DC STEIGBIGEL RT HEWITT RG CAMERON ML DONNELLY MA PACKARD MV BARTLETT JA FIFE KH ZWICKL BW BORUM J BURACK JH DYBECK KA COLEMAN RL JOHNSON WR MCKINLEY GF GRIECO MH KOLATCH BR SEPKOWITZ K PONTICELLO L GIORDANO MF MURRAY HW GOCKE DJ FASS RJ PARA MF STERN JS DREW LJ SPECTOR SA HAVLIR DV NUFFER KL RICHMAN DD CONNOR EM KLOSER PC PICARDI JM VANMATERMINER C LEEDOM JM HOLTOM PD RICHARDSON W EHMANN WC ZURLO JJ KREHER M EYSTER ME HYSLOP NE MUSHATT DM HOADLEY DJ ZACHARY JA SIMON GL PARENTI DM LELACHEUR S SCHUCK S HO MT MCMAHON DK PAZIN GJ ROSENER R CHEESEMAN SH MANGINI LA SANDS MG KAZIAL K JONES G PETTINELLI CB LANDRY B MARTINEZ AI
Citation: Ma. Fischl et al., COMBINATION AND MONOTHERAPY WITH ZIDOVUDINE AND ZALCITABINE IN PATIENTS WITH ADVANCED HIV DISEASE, Annals of internal medicine, 122(1), 1995, pp. 24-32
THERAPY OF HIV-1 INFECTION
Authors: KOZAL MJ MERIGAN TC
Citation: Mj. Kozal et Tc. Merigan, THERAPY OF HIV-1 INFECTION, Current opinion in infectious diseases, 7(1), 1994, pp. 72-81
HIV-1 SYNCYTIUM-INDUCING PHENOTYPE, VIRUS BURDEN CODON-215 REVERSE-TRANSCRIPTASE MUTATION AND CD4 CELL DECLINE IN ZIDOVUDINE-TREATED PATIENTS
Authors: KOZAL MJ SHAFER RW WINTERS MA KATZENSTEIN DA AGUINIGA E HALPERN J MERIGAN TC
Citation: Mj. Kozal et al., HIV-1 SYNCYTIUM-INDUCING PHENOTYPE, VIRUS BURDEN CODON-215 REVERSE-TRANSCRIPTASE MUTATION AND CD4 CELL DECLINE IN ZIDOVUDINE-TREATED PATIENTS, Journal of acquired immune deficiency syndromes, 7(8), 1994, pp. 832-838
DIURNAL AND SHORT-TERM STABILITY OF HIV VIRUS LOAD AS MEASURED BY GENE AMPLIFICATION
Authors: HOLODNIY M MOLE L WINTERS M MERIGAN TC
Citation: M. Holodniy et al., DIURNAL AND SHORT-TERM STABILITY OF HIV VIRUS LOAD AS MEASURED BY GENE AMPLIFICATION, Journal of acquired immune deficiency syndromes, 7(4), 1994, pp. 363-368
HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEINS
Authors: MERIGAN TC KUNDU SK
Citation: Tc. Merigan et Sk. Kundu, HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEINS, Journal of acquired immune deficiency syndromes, 7, 1994, pp. 190000014-190000020
FACTORS INFLUENCING HIV RESPONSES TO DIDEOXY DRUGS
Authors: MERIGAN TC
Citation: Tc. Merigan, FACTORS INFLUENCING HIV RESPONSES TO DIDEOXY DRUGS, AIDS research and human retroviruses, 10, 1994, pp. 190000023-190000023
DISPOSITION OF ANTIGEN-PRESENTING LIPOSOMES IN-VIVO - EFFECT ON PRESENTATION OF HERPES-SIMPLEX VIRUS-ANTIGEN RGD
Authors: HO RJY BURKE RL MERIGAN TC
Citation: Rjy. Ho et al., DISPOSITION OF ANTIGEN-PRESENTING LIPOSOMES IN-VIVO - EFFECT ON PRESENTATION OF HERPES-SIMPLEX VIRUS-ANTIGEN RGD, Vaccine, 12(3), 1994, pp. 235-242
DETECTION OF DRUG-RESISTANCE MUTATIONS IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) POL GENE - DIFFERENCES IN SEMEN AND BLOOD HIV-1 RNA AND PROVIRAL DNA
Authors: KROODSMA KL KOZAL MJ HAMED KA WINTERS MA MERIGAN TC
Citation: Kl. Kroodsma et al., DETECTION OF DRUG-RESISTANCE MUTATIONS IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) POL GENE - DIFFERENCES IN SEMEN AND BLOOD HIV-1 RNA AND PROVIRAL DNA, The Journal of infectious diseases, 170(5), 1994, pp. 1292-1295
FAILURE OF SHORT-TERM CD4-PE40 INFUSIONS TO REDUCE VIRUS LOAD IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS
Authors: RAMACHANDRAN RV KATZENSTEIN DA WOOD R BATTS DH MERIGAN TC
Citation: Rv. Ramachandran et al., FAILURE OF SHORT-TERM CD4-PE40 INFUSIONS TO REDUCE VIRUS LOAD IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS, The Journal of infectious diseases, 170(4), 1994, pp. 1009-1013
LONG-TERM EFFECTS OF INTERLEUKIN-2 ON CD4 CELL COUNTS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
Authors: RAMACHANDRAN RV KATZENSTEIN D MERIGAN TC
Citation: Rv. Ramachandran et al., LONG-TERM EFFECTS OF INTERLEUKIN-2 ON CD4 CELL COUNTS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, The Journal of infectious diseases, 170(4), 1994, pp. 1044-1046
DEFICIENCY IN ANTIBODY-RESPONSE TO HUMAN CYTOMEGALOVIRUS GLYCOPROTEINGH IN HUMAN IMMUNODEFICIENCY VIRUS-TREATED PATIENTS AT RISK FOR CYTOMEGALOVIRUS RETINITIS
Authors: RASMUSSEN L MORRIS S WOLITZ R DOWLING A FESSELL J HOLODNIY M MERIGAN TC
Citation: L. Rasmussen et al., DEFICIENCY IN ANTIBODY-RESPONSE TO HUMAN CYTOMEGALOVIRUS GLYCOPROTEINGH IN HUMAN IMMUNODEFICIENCY VIRUS-TREATED PATIENTS AT RISK FOR CYTOMEGALOVIRUS RETINITIS, The Journal of infectious diseases, 170(3), 1994, pp. 673-677
COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE SELECTS FOR DRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS WITH UNIQUE PATTERNS OF POL GENE-MUTATIONS
Authors: SHAFER RW KOZAL MJ WINTERS MA IVERSEN AKN KATZENSTEIN DA RAGNI MV MEYER WA GUPTA P RASHEED S COOMBS R KATZMAN M FISCUS S MERIGAN TC
Citation: Rw. Shafer et al., COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE SELECTS FOR DRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS WITH UNIQUE PATTERNS OF POL GENE-MUTATIONS, The Journal of infectious diseases, 169(4), 1994, pp. 722-729
QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS BY CULTURE AND POLYMERASE CHAIN-REACTION IN RESPONSE TO DIDANOSINE AFTER LONG-TERM THERAPY WITH ZIDOVUDINE
Authors: KATZENSTEIN DA WINTERS M BUBP J ISRAELSKI D WINGER E MERIGAN TC
Citation: Da. Katzenstein et al., QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS BY CULTURE AND POLYMERASE CHAIN-REACTION IN RESPONSE TO DIDANOSINE AFTER LONG-TERM THERAPY WITH ZIDOVUDINE, The Journal of infectious diseases, 169(2), 1994, pp. 416-419
RELATIONSHIP OF HIV-1 PROVIRUS LOAD, CD8-CELLS AND HIV-1 ENVELOPE-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN HIV-INFECTED ASYMPTOMATIC PATIENTS( CD11+ T)
Authors: KUNDU SK MERIGAN TC
Citation: Sk. Kundu et Tc. Merigan, RELATIONSHIP OF HIV-1 PROVIRUS LOAD, CD8-CELLS AND HIV-1 ENVELOPE-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN HIV-INFECTED ASYMPTOMATIC PATIENTS( CD11+ T), Immunology, 83(1), 1994, pp. 81-85
DIDANOSINE RESISTANCE IN HIV-INFECTED PATIENTS SWITCHED FROM ZIDOVUDINE TO DIDANOSINE MONOTHERAPY
Authors: KOZAL MJ KROODSMA K WINTERS MA SHAFER RW EFRON B KATZENSTEIN DA MERIGAN TC
Citation: Mj. Kozal et al., DIDANOSINE RESISTANCE IN HIV-INFECTED PATIENTS SWITCHED FROM ZIDOVUDINE TO DIDANOSINE MONOTHERAPY, Annals of internal medicine, 121(4), 1994, pp. 263-268
HIV RESISTANCE TO DIDEOXYNUCLEOSIDE INHIBITORS
Authors: KOZAL MJ MERIGAN TC
Citation: Mj. Kozal et Tc. Merigan, HIV RESISTANCE TO DIDEOXYNUCLEOSIDE INHIBITORS, Infectious diseases in clinical practice, 2(4), 1993, pp. 247-253
COMBINATION ANTI-HIV THERAPY - QUESTIONS AND ANSWERS
Authors: MERIGAN TC
Citation: Tc. Merigan, COMBINATION ANTI-HIV THERAPY - QUESTIONS AND ANSWERS, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 676-676
CONTINUOUS PRESENCE OF CD4-PE40 IS REQUIRED FOR ANTIVIRAL ACTIVITY AGAINST SINGLE-PASSAGE HIV ISOLATES AND INFECTED PERIPHERAL-BLOOD MONONUCLEAR-CELLS
Authors: WINTERS MA MERIGAN TC
Citation: Ma. Winters et Tc. Merigan, CONTINUOUS PRESENCE OF CD4-PE40 IS REQUIRED FOR ANTIVIRAL ACTIVITY AGAINST SINGLE-PASSAGE HIV ISOLATES AND INFECTED PERIPHERAL-BLOOD MONONUCLEAR-CELLS, AIDS research and human retroviruses, 9(11), 1993, pp. 1091-1096
BIOLOGICAL VARIATION AND QUALITY-CONTROL OF PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA QUANTITATION BY REVERSE-TRANSCRIPTASE POLYMERASECHAIN-REACTION
Authors: WINTERS MA TAN LB KATZENSTEIN DA MERIGAN TC
Citation: Ma. Winters et al., BIOLOGICAL VARIATION AND QUALITY-CONTROL OF PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA QUANTITATION BY REVERSE-TRANSCRIPTASE POLYMERASECHAIN-REACTION, Journal of clinical microbiology, 31(11), 1993, pp. 2960-2966
PERIPHERAL-BLOOD MONONUCLEAR CELL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1PROVIRAL DNA QUANTIFICATION BY POLYMERASE CHAIN-REACTION - RELATIONSHIP TO IMMUNODEFICIENCY AND DRUG EFFECT
Authors: MONTOYA JG WOOD R KATZENSTEIN D HOLODNY M MERIGAN TC
Citation: Jg. Montoya et al., PERIPHERAL-BLOOD MONONUCLEAR CELL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1PROVIRAL DNA QUANTIFICATION BY POLYMERASE CHAIN-REACTION - RELATIONSHIP TO IMMUNODEFICIENCY AND DRUG EFFECT, Journal of clinical microbiology, 31(10), 1993, pp. 2692-2696
Risultati: 1-25 | 26-50 | 51-75 |